Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Alliance to Develop vCJD Blood Test

By HospiMedica staff writers
Posted on 18 Dec 2001
An exclusive agreement to develop a human blood test for variant Creutzfeldt-Jacob disease (vCJD) has been announced by Ortho-Clinical Diagnostics, Inc. More...
(OCD, Raritan, NJ, USA) and Caprion Pharmaceuticals Inc. (Montreal, Canada). Currently, no diagnostic test exists to screen for vCJD in the blood supply, according to the two companies.

The arrangement is an extension of an earlier research collaboration, where OCD exercised an option to license Caprion's prion technologies, including unique monoclonal antibodies for the detection of the agent responsible for vCJD. Caprion employs a proprietary, integrated subcellular proteomics discovery platform and expertise in cell fractionation to create comprehensive intracellular maps identifying the location, orientation, and movement of human proteins. OCD has obtained worldwide exclusive rights to the test for the marketing and distribution of human in vitro diagnostic applications and will fund all development activities and regulatory expenses.

"Health-care agencies worldwide are striving to ensure that blood supplies are safe, and the development of a test for vCJD would allow them to do so,” said Catherine M. Burzik, president of OCD.




Related Links:
Caprion
Ortho

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.